Dov Pharmaceuticals Inc., XTL deal

DOV received $7.5 million up front, $5 million of which went to Wyeth (WYE, Madison, N.J.) as a milestone under the partners' 2004 amendments to a 1997 deal (see BioCentury, March 1, 2004, & July 7, 1997). DOVP is eligible for $126.5 million in milestones, plus escalating low double-digit royalties. ...